Evaluation of the effects of ultra-long acting insulin analogue on diabetic vascular complicatio
Not Applicable
- Conditions
- Type2 diabetes
- Registration Number
- JPRN-UMIN000004973
- Lead Sponsor
- EVOLUTION study group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
Patients modified ACEI/ARB, statin, pioglitzone therapy within 1 months Patients with pregnancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method